W
WLC

Topic

semaglutide

2 articles on semaglutide in longevity medicine. View all news →

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes Peer-reviewed

GLP-1s in Longevity Clinics: Metabolic Health, Muscle Loss, and Red Flags (2026)

A 2026 buyer guide to GLP-1s in longevity clinics: when they make medical sense, how to protect muscle, and which red flags to avoid.

GLP-1 longevity clinic semaglutide tirzepatide
Science News: GLP-1 microdosers are chasing longevity

GLP-1 Microdosing for Longevity: Evidence, Risks, and Clinic Red Flags (2026)

GLP-1 microdosing longevity clinics in 2026 need scrutiny: see evidence, healthy-lean caveats, product-quality risks, and buyer red flags.

GLP-1 microdosing semaglutide longevity clinics